InsiderSignal.AI

InsiderSignal.ai

CBLL - Ceribell, Inc.

Insider Sale by Woo Raymond (CTO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Woo Raymond, serving as CTO at Ceribell, Inc. (CBLL), sold 11,112 shares at $18.56 per share, for a total transaction value of $206,244.00. Following this transaction, Woo Raymond now holds 197,648 shares of CBLL.

This sale represents a 5.00% decrease in Woo Raymond's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, April 1, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 3, 2026, 2 days after the trade was made.

Ceribell, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Woo Raymond

Woo Raymond

CTO

Raymond Woo, Ph.D., age 43, is the Chief Technology Officer (CTO) at Ceribell, Inc. (NASDAQ: CBLL), a medical device company specializing in EEG technology, a role he has held since February 2017 after serving as Vice President of Engineering from June 2016 to February 2017[[1]](https://fintool.com/app/research/companies/CBLL/people/raymond-woo)[[4]](https://ceribell.com/about-us/leadership-team/). He leads product research and development efforts at Ceribell, contributing to innovations like the Ceribell Instant EEG Headcap[[8]](https://www.accessdata.fda.gov/cdrh_docs/pdf22/K223086.pdf)[[9]](https://siren.network/wp-content/uploads/2025/04/K232052_FDA-letter_08.07.2023.pdf). Woo holds a B.S. in electrical engineering and computer science from Duke University and a Ph.D. in electrical engineering from Stanford University[[1]](https://fintool.com/app/research/companies/CBLL/people/raymond-woo)[[4]](https://ceribell.com/about-us/leadership-team/). Prior to Ceribell, Woo held various roles at OptiMedica Corporation from September 2011 to 2013, followed by positions at Abbott Medical Optics, Inc., including Global Head of Femtosecond Laser R&D from August 2013 to May 2016, and served as Senior Engineer at Exponent Failure Analysis Associates from January 2009 to September 2011[[1]](https://fintool.com/app/research/companies/CBLL/people/raymond-woo)[[4]](https://ceribell.com/about-us/leadership-team/). As a corporate insider, he recently sold shares, including 705 shares on February 23, 2026, at $19.79, and larger tranches earlier in the year[[5]](https://www.marketbeat.com/instant-alerts/insider-selling-ceribell-nasdaqcbll-cto-sells-705-shares-of-stock-2026-02-25/)[[6]](https://www.sahmcapital.com/news/content/ceribell-cto-raymond-woo-disposes-of-common-shares-2026-03-04). His compensation includes a 2024 base salary of $337,500 (adjusted to $342,000 mid-year), with bonuses tied to corporate metrics like revenue and R&D milestones[[1]](https://fintool.com/app/research/companies/CBLL/people/raymond-woo).

View full insider profile →

Trade Price

$18.56

Quantity

11,112

Total Value

$206,244.00

Shares Owned

197,648

Trade Date

Wednesday, April 1, 2026

3 days ago

SEC Filing Date

Friday, April 3, 2026

Filed 2 days after trade

HEALTHCAREMEDICAL DEVICES

About Ceribell, Inc.

Company Overview

No company information available
View news mentioning CBLL

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5330952

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime